| Myo-inositol Versus Clomiphene Citrate in PCOS (NCT04306692) | University Hospital, Ghent | 2020-07-02 |
| Letrozole Versus Gonadotropins in Clomiphene Citrate Resistance (NCT04834791) | Tanta University | 2019-03-01 |
| Effect of Adding Isoflavonoids to Clomiphene Citrate for Ovulation Induction in Women With Polycystic Ovary Syndrome (NCT04610957) | FAlbasri | 2019-01-01 |
| Agonist Versus Classical HCG Trigger (Poor Responders, Normoresponders and High Responders) (NCT03307720) | Ginegorama S.L. | 2017-12-18 |
| Effect of Vitamin D Supplement in Induction of Ovulation in Overweight Women With Polycystic Ovary Syndrome (NCT03396380) | Ain Shams University | 2017-07-01 |
| Follicular Long GnRH Agonist Versus Antagonist Protocol in PCOS Women Undergoing in Vitro Fertilization (NCT02496754) | The First Affiliated Hospital of Zhengzhou University | 2016-06-01 |
| GnRH Agonist Versus hCG Trigger in Ovulation Induction With Intrauterine Insemination. (NCT03825445) | Hue University of Medicine and Pharmacy | 2016-04-01 |
| Evolutive Potential of Embryos Obtained From Oocytes After Luteal Phase Ovarian Stimulation (NCT01645241) | Fundacion Dexeus | 2012-07-01 |
| Traditional Clomiphene Citrate Administration vs. Stair-step Approach (NCT01008319) | University of Oklahoma | 2009-10-01 |
| Recombinant Follicle Stimulating Hormone (FSH) (Gonal-f®): Use in Ovulation Induction (NCT01081626) | Merck KGaA, Darmstadt, Germany | 2009-03-01 |
| Trial Comparing Start Stimulation of Recombinant Follicle Stimulating Hormone (rFSH) on Cycle Day 2 Versus Cycle Day 5 in In Vitro Fertilization (IVF) (NCT00823472) | UMC Utrecht | 2009-01-01 |
| AS900672-Enriched in Ovulation Induction (NCT00553514) | Merck KGaA, Darmstadt, Germany | 2007-12-01 |
| A Phase II Study to Assess the Efficacy and Safety of Luveris® (Lutropin Alfa) in Mid Follicular Phase for Controlled Ovarian Stimulation (COS) in Advanced Reproductive Age (NCT01079949) | Merck KGaA, Darmstadt, Germany | 2007-11-01 |
| A Phase 2 Trial to Evaluate if Corifollitropin Alfa (Org 36286), Followed by a Low Daily Dose of hCG or Recombinant FSH Can Induce Monofollicular Growth in Women With WHO Group II Anovulatory Infertility (P05693) (NCT00697255) | Organon and Co | 2007-05-15 |
| SJ-0021 (Gonalef®) Versus Purified Pituitary Gonadotropin (Fertinorm-P®) for Ovulation Induction in Japanese Infertile Women (NCT01185782) | Merck KGaA, Darmstadt, Germany | 2007-02-01 |
| A Randomised, Phase II, Comparative Study With a Parallel Control for Evaluating the Efficacy and Safety of Combined Treatment of Lutropin Alpha and Recombinant Human Luteinizing Hormone in the Middle of the Controlled Ovarian Stimulation Follicular Phase in Women With Reduced Ovarian Reserve (NCT01110707) | Merck KGaA, Darmstadt, Germany | 2005-01-10 |
| Convenience and Safety of Assisted Reproductive Technology Procedures Using a Gonal-F Filled by Mass (Fbm) Liquid Formulation Applied by Pen for Ovulation Induction and In-vitro Fertilization (NCT01183143) | Merck KGaA, Darmstadt, Germany | 2004-05-11 |
| A Prospective, Multi-centric Observational Study to Determine the Mono-bifollicular Development in Infertile Women Subjected to Ovulation Induction With Follitropin α (NCT01111084) | Merck KGaA, Darmstadt, Germany | 2004-03-01 |
| An Open Label, Canadian Phase IIIb Study With Ovidrel in Ovulation Induction (OI) and Assisted Reproductive Technique (ART) (NCT01152866) | EMD Serono | 2003-12-01 |
| To Evaluate the Convenience, Safety and Efficacy of Follitropin Alfa Liquid Pen Compared With Follitropin Beta Liquid Pen (NCT01081639) | Merck KGaA, Darmstadt, Germany | 2003-11-01 |